What You Must Know About Camlin Fine Sciences Limited’s (NSE:CAMLINFINE) Beta Value

In this article:

If you’re interested in Camlin Fine Sciences Limited (NSE:CAMLINFINE), then you might want to consider its beta (a measure of share price volatility) in order to understand how the stock could impact your portfolio. Volatility is considered to be a measure of risk in modern finance theory. Investors may think of volatility as falling into two main categories. The first category is company specific volatility. This can be dealt with by limiting your exposure to any particular stock. The second type is the broader market volatility, which you cannot diversify away, since it arises from macroeconomic factors which directly affects all the stocks on the market.

Some stocks mimic the volatility of the market quite closely, while others demonstrate muted, exagerrated or uncorrelated price movements. Some investors use beta as a measure of how much a certain stock is impacted by market risk (volatility). While we should keep in mind that Warren Buffett has cautioned that ‘Volatility is far from synonymous with risk’, beta is still a useful factor to consider. To make good use of it you must first know that the beta of the overall market is one. A stock with a beta greater than one is more sensitive to broader market movements than a stock with a beta of less than one.

See our latest analysis for Camlin Fine Sciences

What does CAMLINFINE’s beta value mean to investors?

Given that it has a beta of 0.89, we can surmise that the Camlin Fine Sciences share price has not been strongly impacted by broader market volatility (over the last 5 years). If history is a good guide, owning the stock should help ensure that your portfolio is not overly sensitive to market volatility. Many would argue that beta is useful in position sizing, but fundamental metrics such as revenue and earnings are more important overall. You can see Camlin Fine Sciences’s revenue and earnings in the image below.

NSEI:CAMLINFINE Income Statement Export November 16th 18
NSEI:CAMLINFINE Income Statement Export November 16th 18

Could CAMLINFINE’s size cause it to be more volatile?

Camlin Fine Sciences is a noticeably small company, with a market capitalisation of ₹6.9b. Most companies this size are not always actively traded. Very small companies often have a low beta value because their share prices are not well correlated with market volatility. This could be because the price is reacting to company specific events. Alternatively, the shares may not be actively traded.

What this means for you:

The Camlin Fine Sciences doesn’t usually show much sensitivity to the broader market. This could be for a variety of reasons. Typically, smaller companies have a low beta if their share price tends to move a lot due to company specific developments. Alternatively, an strong dividend payer might move less than the market because investors are valuing it for its income stream. This article aims to educate investors about beta values, but it’s well worth looking at important company-specific fundamentals such as Camlin Fine Sciences’s financial health and performance track record. I urge you to continue your research by taking a look at the following:

  1. Future Outlook: What are well-informed industry analysts predicting for CAMLINFINE’s future growth? Take a look at our free research report of analyst consensus for CAMLINFINE’s outlook.

  2. Past Track Record: Has CAMLINFINE been consistently performing well irrespective of the ups and downs in the market? Go into more detail in the past performance analysis and take a look at the free visual representations of CAMLINFINE’s historicals for more clarity.

  3. Other Interesting Stocks: It’s worth checking to see how CAMLINFINE measures up against other companies on valuation. You could start with this free list of prospective options.

To help readers see past the short term volatility of the financial market, we aim to bring you a long-term focused research analysis purely driven by fundamental data. Note that our analysis does not factor in the latest price-sensitive company announcements.

The author is an independent contributor and at the time of publication had no position in the stocks mentioned. For errors that warrant correction please contact the editor at editorial-team@simplywallst.com.

Advertisement